Found: 21
Select item for more details and to access through your institution.
Maternal factors and breast cancer risk among young women.
- Published in:
- 1998
- By:
- Publication type:
- journal article
BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Disseminated Canine Herpesvirus-1 Infection in an Immunocompromised Adult Dog.
- Published in:
- Journal of Veterinary Internal Medicine, 2010, v. 24, n. 4, p. 965, doi. 10.1111/j.1939-1676.2010.0512.x
- By:
- Publication type:
- Article
Re: Tamoxifen and contralateral breast cancer: the other side.
- Published in:
- 2001
- By:
- Publication type:
- Letter
Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Pregnancy after breast carcinoma: outcomes and influence on mortality.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2008, v. 47, n. 12, p. 1049, doi. 10.1002/gcc.20610
- By:
- Publication type:
- Article
Breast cancer risk in young women and history of selected medical conditions.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study.
- Published in:
- 2008
- By:
- Publication type:
- journal article
ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Epidemiologic and molecular risk factors for contralateral breast cancer among young women.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Hormonal content and potency of oral contraceptives and breast cancer risk among young women.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood.
- Published in:
- 1999
- By:
- Publication type:
- journal article
A prospective evaluation of the impact of second-opinion histopathology on diagnostic testing, cost and treatment in dogs and cats with cancer.
- Published in:
- Veterinary & Comparative Oncology, 2015, v. 13, n. 2, p. 106, doi. 10.1111/vco.12023
- By:
- Publication type:
- Article
Comparison of two questionnaires to assess gastrointestinal toxicity in dogs and cats treated with chemotherapy.
- Published in:
- Veterinary & Comparative Oncology, 2011, v. 9, n. 3, p. 225, doi. 10.1111/j.1476-5829.2010.00259.x
- By:
- Publication type:
- Article
Comparison between -CHOP and an -CHOP protocol with interposed treatments of CCNU and MOPP (-CHOP-CCNU-MOPP) for lymphoma in dogs K. M. Rassnick et al.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 4, p. 243, doi. 10.1111/j.1476-5829.2010.00224.x
- By:
- Publication type:
- Article
Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumours.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 3, p. 209, doi. 10.1111/j.1476-5829.2010.00223.x
- By:
- Publication type:
- Article
A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.
- Published in:
- Veterinary & Comparative Oncology, 2010, v. 8, n. 2, p. 138, doi. 10.1111/j.1476-5829.2010.00217.x
- By:
- Publication type:
- Article